October 15, 2020
…response and production of neutralizing antibodies. (NOTE: The AstraZeneca trial was paused in mid-September when a participant in the UK trial developed serious neurological symptoms. The participant recovered and the trial resumed in the UK and in other countries but remains on hold in the United States.) Join a COVID-19…
May 13, 2021
…data indicate that the neutralizing antibodies elicited by the Moderna and Pfizer mRNA vaccines last for at least six months, which is excellent news. These studies are ongoing and will continue to look at the protection over time, so we don’t yet know exactly how long vaccine protection lasts. It…
February 28, 2012
The U.S. Office of Naval Research (ONR) has announced the shipyard responsible for constructing the next chapter in ocean exploration for Scripps Institution of Oceanography at UC San Diego. The new research vessel will be owned by ONR for the Department of the Navy and operated by Scripps under charter…
November 19, 2012
For work toward a safer approach to treating cancer, electrical engineering Ph.D. student Inanc Ortac from the University of California, San Diego has won first prize in the graduate student category at the 2012 Collegiate Inventors Competition.
December 2, 2013
Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This “nanosponge vaccine” enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA—both within the bloodstream and on…
August 25, 2015
Nanoengineers at the University of California, San Diego used an innovative 3D printing technology they developed to manufacture multipurpose fish-shaped microrobots — called microfish — that are efficient swimmers, are chemically powered and magnetically controlled. These proof-of-concept synthetic microfish will inspire a new generation of “smart” microrobots that have diverse…
November 6, 2017
A study led by Kevin King, a bioengineer and physician at the University of California San Diego, has found that the immune system plays a surprising role in the aftermath of heart attacks. The research could lead to new therapeutic strategies for heart disease. Researchers present their findings in the…
July 9, 2020
Researchers at University of California San Diego School of Medicine and UC San Diego Health have launched a clinical trial to assess the safety and efficacy of convalescent plasma (CP) to prevent COVID-19 after a known exposure to the virus.
July 15, 2020
From mRNA vaccines entering clinical trials, to peptide-based vaccines and using molecular farming to scale vaccine production, the COVID-19 pandemic is pushing new and emerging nanotechnologies into the frontlines and the headlines.
July 24, 2020
UC San Diego Health and the Altman Clinical and Translational Research Institute will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intended to protect against SARS-CoV-2, the coronavirus that causes COVID-19.
